Immunosuppressive activity of concanavalin A

Science
H MarkowitzR E Ritts

Abstract

Two strains of mice (C-57 B] and DBA) were given skin allografts from Swiss ICR/HA mice and were treated with varying doses of concanavalin A; the dosage ranged from only two injections of 25 micrograms during the experiment to daily doses of 1000 micrograms intraperitoneally. Immullosuppression was present at all dosages, the most prolonged and consistent effect being observed at 300 micrograms per day. Grafts survived for 14 to 21 days at this dosage compared to 4 to 9 days for controls.

References

Sep 1, 1965·Archives of Biochemistry and Biophysics·S Nakamura, R Suzuno
Dec 25, 1964·Science·J H ROBBINS

❮ Previous
Next ❯

Citations

May 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E De MaeyerM Vandeputte
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·B M Wimer
Oct 1, 1987·Journal of Interferon Research·A Billiau
Jul 1, 1976·European Journal of Immunology·R A Calderón, F Córdoba
Mar 1, 1970·The Journal of Asthma Research·A Lietze
Nov 1, 1976·CRC Critical Reviews in Biochemistry·H M Johnson, S Baron
Jun 1, 1969·Archives of Biochemistry and Biophysics·N Catsimpoolas, E W Meyer
Jul 1, 1971·The Journal of Surgical Research·M W AshbyY Nosé
Jan 1, 1975·Immunological Communications·S DavisG R Pearson
Jul 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Markus Biburger, Gisa Tiegs
Nov 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R VerloesG Atassi
Feb 21, 2006·Biosensors & Bioelectronics·Ralph BallerstadtAshok Gowda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J G Waldenström
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
G Schwarze, A Pappas
© 2021 Meta ULC. All rights reserved